Omega-3 may slow some mental decline from Alzheimer’s
Dated: 13 October 2006
Omega-3 fatty acid supplements may slow cognitive decline in some patients with very mild Alzheimer's disease, according to a small clinical trial published in the October issue of Archives of Neurology. While omega-3 fatty acids do not appear to improve the brain functioning of patients with more advanced cases, and larger, long-term studies are needed, this comes as good news.
Alzheimer's disease is a severely debilitating condition that affects thinking, learning and memory, beginning with declines in memory (including memory about events in one's own life). Medications are available to treat the symptoms, but these drugs do not affect the underlying cause and progression of the disease. Several studies have shown that eating fish, which is high in omega-3 fatty acids, may protect against Alzheimer's disease, leading researchers to question whether supplements could have similar effects.
Yvonne Freund-Levi, MD, Karolinska Institutet, Stockholm, Sweden, and colleagues compared the effects of supplements containing two omega-3 fatty acids with placebo in 204 patients with Alzheimer's disease, 174 of whom completed the entire study. For six months, 89 patients (51 women and 38 men) took 1.7 grams of docosahexaenoic acid (DHA) and 0.6 grams of eicosapentaenoic acid (EPA); meanwhile 85 patients (39 women and 46 men) took placebo. For an additional six months, both groups took the omega-3 fatty acids. Patients had physical examinations, which included blood tests and blood pressure measurement, and took cognitive tests at the beginning of the study and at the six- and 12-month marks.
After six months, there was no difference in the rate of cognitive decline between the two groups. However, among a subgroup of 32 patients with very mild mental impairment at the beginning of the study, those who took the fatty acids experienced less decline in six months compared with those who took placebo. Among those who took placebo during the first six months, decline decreased during the second six months, when they also began taking the omega-3 supplements. The supplements appeared safe and well-tolerated, with no change in blood pressure or blood test results other than a higher ratio of fatty acids in the blood.
"The mechanisms by which omega-3 fatty acids could interfere in Alzheimer's disease pathophysiologic features are not clear, but since anti-inflammatory effects are an important part of the profile of fish oils, they are conceivable also for Alzheimer's disease," the authors write.
The authors caution that "these findings cannot serve as a basis for general recommendations for treatment of Alzheimer's disease with dietary DHA-rich fish oil preparations. However, studies in larger cohorts with mild cognitive impairment, including those at risk for Alzheimer's disease, are needed to further explore the possibility that omega-3 fatty acids might be beneficial in halting initial progression of the disease."
(1 September 2008) The consumption of health food continues to grow in Southeast Asia as more become aware that what they eat affects their health in the long run. Aiding to this growth is the stead...
(1 September 2008) Synergy Production Laboratories (SPL) has introduced an organic green superfood blend with 29 premium certified organic, whole-food ingredients(e.g.vegetables, berries, algae, gra...
(1 September 2008) Givaudan Flavours has launched a range of lemon oil replacement ingredients. Part of the company’s SUNthesis engineered citrus ingredients collection, the range has been designed ...
(1 September 2008) Recent Study on Prolibra Weight Management Solution A human clinical trial has shown that Prolibra, a weight management solution from Glanbia Nutritionals, considerably reduces pos...
(1 September 2008) Consumers are choosing premium and indulgent confectionery products as manufacturers offer healthful products. Manufacturers are working to ensure that their confectionery products...
(1 September 2008) Novel active ingredients in personal care products are becoming the main driving force behind developments in the market. Active ingredients with anti-ageing and antiwrinkling fun...
(1 September 2008) Danisco Sugar has inaugurated a new plant for the production of bioethanol based on sugar beet. The plant, which is located adjacent to Danisco Sugar’s sugar factory in Anklam in G...
(1 September 2008) Competition has generated a need for cost-effective ingredients that can mimic the texture of meat or replace expensive binders such as soy protein isolate, modified food starches...
Germany's METRO Group is making plans to open its first Metro Cash & Carry wholesale store in Kazakhstan in the summer of 2009. The Group officially agreed to the investment with the Government of the Republic of Kazakhstan on Wednesday, a move which will extend METRO's activities to 33 countries.
Trent Ltd, the retail arm of the Tata group in India, is likely to invest around Rs 20billion ( €0.3 billion ) over the next five years in the roll out of 50 Star Bazaar hypermarket stores, according to Indian press reports.
The recent credit crunch has led all the major supermarket chains in the UK to increase promotions of cheap, unhealthy food, according to the country's National Consuner Council (NCC).
Auchan has published half year results for the first time as a result of new European regulations governing transparency. Although there has been a slow-down in mature markets, emerging markets remained buoyant for the French company and as a result sales for the first six months of 2008 were 9.4% higher than in 2007 reaching EUR18.7 billion.
Price promotions and the decision to only partially pass on food price inflation to customers have led to a downturn in second quarter margins for Ahold. Net sales for second quarter 2008 were EUR 5.8 billion, down 0.8% from the same period last year. At constant exchange rates, net sales increased by 7.3%.
Despite the credit crunch, drinks giant, Diageo reports another year of strong organic growth with net sales up 7% and operating profit up 9%. Sales rose to £8.09bn up from £7.48bn last year while sales volumes increased by about 3%.
